Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Weight Loss Associated with Semaglutide Use is Linked to Improved Reproductive Measures in PMOS: a Proof-Of-Concept Analysis
Fertility and sterility, 2026
Copper(II)-Tripeptide Complexes as Potential Skin Healing Agents: Synthesis, Characterization, and Wound Repair Ability
ChemMedChem;21(8):e202501023
Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes
United European gastroenterology journal;14(5):e70238
Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation
Integrative medicine (Encinitas, Calif.);25(2):29-37
Biomimetic Hematoma Enables Healing in Complex Periprosthetic Fracture Nonunion with Multiple Comorbidities: A Case Report
JBJS case connector, 2026;16(2)
Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety
Obesity surgery, 2026
Dual GIP/GLP-1 receptor agonist tirzepatide ameliorates hepatic steatosis and inflammatory responses in a MASLD mouse model associated with the CCL2/CCR2 axis
BMC gastroenterology, 2026
Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
Dermatology and therapy, 2026
Rates of, Reasons for, and Reactions to Discontinuation of GLP-1 Receptor Agonists: A Narrative Review
Diabetes, obesity & metabolism, 2026
A subphenotype of obesity with reduced enteroendocrine GLP-1 synthesis and enhanced tirzepatide response
Gastroenterology, 2026
Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care
Diabetology international, 2026;17(3):59
Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma
Frontiers in endocrinology, 2026;17:1768254
Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
Frontiers in aging neuroscience, 2026;18:1851072
Clinical Effectiveness and Safety of Oral Semaglutide in a Real-World Cohort of Patients with Heart Failure with Reduced Ejection Fraction, Type 2 Diabetes and Obesity: A Propensity Score-Matched Analysis
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Incretin-based therapies and altered myocardial metabolism in a swine model of ischemic heart disease in the setting of metabolic syndrome
Surgery, 2026;:110369
Diabetic Status, Advanced Age, and Hispanic Ethnicity Predict Poorer Weight Loss in Patients with Obesity on Semaglutide
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
Disproportionality Analysis of Tirzepatide-Associated Ketoacidosis
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi-Dose Pens
Obesity (Silver Spring, Md.), 2026
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study
Diabetes, obesity & metabolism, 2026
Starvation ketosis following self-administered tirzepatide obtained via online services in a young woman later diagnosed with anorexia nervosa: a case report
Journal of eating disorders, 2026